Oramed Pharmaceuticals
ORMP
#9112
Rank
โ‚น7.94 B
Marketcap
โ‚น197.00
Share price
-2.54%
Change (1 day)
-16.20%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): โ‚น2.05 Billion

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of โ‚น0.61 Billion, an increase over its 2022 earnings that were of -โ‚น3.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น2.05 B236.19%
2023 โ‚น0.61 B-119.45%
2022 -โ‚น3.14 Billion39.17%
2021 -โ‚น2.26 Billion73.93%
2020 -โ‚น1.3 Billion18.53%
2019 -โ‚น1.1 Billion-16.62%
2018 -โ‚น1.32 Billion38.32%
2017 -โ‚น0.95 Billion12.51%
2016 -โ‚น0.85 Billion25.01%
2015 -โ‚น0.68 Billion18.18%
2014 -โ‚น0.58 Billion39.72%
2013 -โ‚น0.41 Billion46.4%
2012 -โ‚น0.28 Billion128.32%
2011 -โ‚น0.13 Billion-51.47%
2010 -โ‚น0.26 Billion35.21%
2009 -โ‚น0.19 Billion
2007 -โ‚น0.3 Billion607.04%
2006 -โ‚น41.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น43.22 Billion-2,147.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.622 T 76,757.93%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
โ‚น680.23 B 32,128.38%๐Ÿ‡ซ๐Ÿ‡ท France
-โ‚น0.84 Billion-139.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-โ‚น17.17 Billion-913.22%๐Ÿ‡บ๐Ÿ‡ธ USA